Anti-pneumococcal vaccines in sickle-cell anemia and asplenism;Vaccins antipneumococciques chez le drépanocytaire et l'asplénique

Presse Medicale

Volumn 32, Issue 28 SUPPL., 2003, Pages

  Cohen, R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; VACCINE; ANTIINFECTIVE AGENT; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; ASPLENIA; BACTERIAL INFECTION; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; NEISSERIA MENINGITIDIS; SICKLE CELL ANEMIA; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION; ADULT; AGE; CHILD; IMMUNIZATION; NEWBORN; PRESCHOOL CHILD; RECURRENT DISEASE; SPLENECTOMY; TIME;

ADULT; AGE FACTORS; ANEMIA, SICKLE CELL; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL VACCINES; RECURRENCE; SPLENECTOMY; TIME FACTORS; VACCINATION;

EID: 0041779517     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Geslin P. Rapport du centre National de référence du pneumocoque 1997.
2. e édition 1999.
3. Whitney C, Schnaffer W, Butler J. Rethinking recommendations for use of pneumococcal vaccines in adults. CID 2001; 33: 151-6.
4. Fedson D, Musher D, Eskola J. Pneumococcal vaccine. In Plotkin S, Orenstein W Third Ed. Saunders, Philadelphia, 1999; 553-607.
5. Sarnaik S, Kaplan J, Schiffman G, Bryla D, Robbins JB, Schneerson R. Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia. Pediatr Infect Dis J 1990; 9: 181-6.
6. Konradsen HB, Pedersen FK, Henrichsen J. Pneumococcal revaccination of splenectomized children. Pediatr Infect Dis J 1990; 9: 258-63.
7. rd ed. Saunders, 1999; 183-221.
8. Black S, Shinefield H, Fireman B et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19: 187-95.
9. Vernacchio L, Neufeld EJ, McDonald K et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr 1998; 133: 275-8.
10. O'Brien K, Swift A, Winkelstein J et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 among infants with sickle cell disease. Pediatrics 2000; 106: 965-72.
11. th ICAAC, Toronto, Ontario, Canada 2000 Abst 688.
12. MMWR Vol 49/N° RR-9.
13. http://www.sante.gouv.fr/htm/sante/index.htm